F. C. Breedveld

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Michael J. Elliott, Ravinder N. Maini, Marc Feldmann et al. · The Lancet · 1994 · 1.7K citations

Medicine, Clinical Sciences, Immunology +15

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, Cornelia F Allaart et al. · Arthritis & Rheumatism · 2005 · 1.5K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Bernard Combe, R. B. M. Landewé, Cédric Lukas et al. · Annals of the Rheumatic Diseases · 2006 · 799 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Daniel E. Fürst, Edward Keystone, Jürgen Braun et al. · Annals of the Rheumatic Diseases · 2011 · 692 citations

Medicine, Internal Medicine, Pharmacotherapy +16

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study

F. van Gaalen, Suzanne P. Linn-Rasker, W J van Venrooij et al. · Arthritis & Rheumatism · 2004 · 642 citations · Full text

Life Sciences, Immunology, Internal Medicine +17